Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Neurox's inroad into untreatable pain

Neurex's inroad into untreatable pain

Neurex Inc. said it has seen positive early results in what is potentially the first new class of analgesics in 50 years. The new drug, SNX-111, appears to be particularly effective in easing a type of pain that has been untreatable.

The Menlo Park, Calif., company was to report results today from the first segment

Read the full 596 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE